NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Sets New 52-Week High – Should You Buy?

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN)’s stock price hit a new 52-week high during trading on Tuesday . The company traded as high as C$5.77 and last traded at C$5.74, with a volume of 262359 shares trading hands. The stock had previously closed at C$5.72.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on NWH.UN. BMO Capital Markets raised their price target on NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a report on Thursday, November 13th. CIBC lifted their target price on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a research note on Thursday, November 13th. Scotiabank boosted their target price on NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a report on Thursday, November 13th. Finally, Royal Bank Of Canada set a C$5.50 price target on NorthWest Health Prop Real Est Inv Trust and gave the stock a “sector perform” rating in a report on Monday, November 24th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of C$6.00.

NorthWest Health Prop Real Est Inv Trust Price Performance

The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42. The stock has a fifty day simple moving average of C$5.37 and a two-hundred day simple moving average of C$5.15. The company has a market cap of C$1.41 billion, a PE ratio of 28.05, a price-to-earnings-growth ratio of 0.74 and a beta of 1.69.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) last issued its earnings results on Tuesday, November 11th. The company reported C$0.06 EPS for the quarter. The company had revenue of C$110.69 million for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative net margin of 75.29% and a negative return on equity of 14.67%. On average, equities analysts predict that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 EPS for the current fiscal year.

About NorthWest Health Prop Real Est Inv Trust

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.